Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study - Proactive Investors Australia

Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study  Proactive Investors Australia

Admedus Ltd (ASX:AHZ) has had its CardioCel transcatheter aortic valve replacement (TAVR) devices validated through the publication of an independent study ...



Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы

Inside Ontario’s ‘scary’ child-welfare system where kids are ‘commodities’ - Global News